ACTA Otorhinolaryngologica Italica https://www.actaitalica.it/ <h1 style="text-align: center;">NEWS!</h1> <h1 style="text-align: center;"><img src="/public/site/images/vbarberi/B_800x200_copia.png" /></h1> <h3 style="text-align: center;"><strong>************************************************************</strong></h3> <h3 style="text-align: center;"> </h3> <h3 style="text-align: center;"> </h3> <p> </p> <h3 style="text-align: center;"><a href="https://www.actaitalica.it/section/view/covid-19-section">Check the latest updates on COVID-19 <br />published in Acta Otorhinolaryngologica Italica</a></h3> <p> </p> <p> </p> en-US <h2><strong>AUTHORSHIP STATEMENT FORM</strong></h2> <p><strong>The corresponding author must sign the </strong><strong>Authorship Statement Form</strong><strong>, save it in .pdf and return it </strong><strong>by uploading at our online submission platform http://www.actaitalica.it/. </strong></p> <p><strong>It is the policy of the Journal to correspond exclusively with one designated corresponding author. As the corresponding author, it is your responsibility to communicate with your co-authors.</strong></p> <p><strong>AUTHORSHIP RESPONSIBILITY</strong></p> <p>(1) All authors participated sufficiently in the intellectual content, analysis of data (if applicable) and writing of the article, as defined by the criteria for authorship by the International Committee of Medical Journal Editors (http://www.icmje.org/). (2)&nbsp;The corresponding author certifies that the definitive version of the manuscript has been approved by all co-authors, as well as, by the director of the Institute or Department where the work has been carried out. (3) All persons who have made substantial contributions to the work reported in this manuscript (e.g., data collection, writing or editing assistance) but who do not fulfill the authorship criteria are named along with their specific contributions as an acknowledgement in the manuscript. The corresponding author certifies that all persons named in the acknowledgement section have provided written permission to be named. (4) All authors have reviewed the final version of the article and approve it for publication. (5) Authors must state that the article submitted has not been previously published, and is not under consideration or accepted for publication (in whole or in part) elsewhere nor have the authors assigned any right or interest in the article to any third party. (6) Written permission from the authors to reproduce any material with copyright elsewhere has been obtained prior to submission. (7) Authors must specify that consent has been obtained from patients taking part in the investigations or, in the case of paediatric patients, from the guardian/s and that they have obtained written releases from patients whose names or photographs are submitted as part of the article. (8) For reports containing original data, the corresponding author should have full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of data analysis. (9) Any manuscript concerned with human subjects, medical records, or human tissue that is submitted to “Acta Otorhinolaryngologica Italica” should comply with the principles stated in the Declaration of Helsinki “Ethical Principles for Medical Research Involving ‘Human Subjects”, adopted by the 18<sup>th</sup> World Medical Assembly, Helsinki, Finland, June 1964, and as amended most recently by the 64<sup>th</sup> World Medical Assembly, Fontaleza, Brazil, October 2013. If the study involves human or animal subjects or records of human patients ethical approval MUST have been obtained. The corresponding author must state whether ethical approval was given, by whom and the relevant Judgement’s reference number. The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was performed, and that subjects gave informed consent to the work. “Acta Otorhinolaryngologica Italica” requires institutional Ethics Committee approval for all human studies. For retrospective studies on patients’ records either a statement of approval or a statement of exemption from the Committee is required. <strong>Ref N° of the Ethical Committee Approval must be indicated in the Authorship Statement Form. The study was approved by the Institutional Ethical Committee (the Name of the Institution must be indicated in the Authorship Statement Form) and this is clearly stated in the Methods section of the article.&nbsp;</strong>This statement should also be provided upon submission of the manuscript. Studies involving experiments with animals must state that their care was in accordance with institution guidelines and relevant national laws. (10) The article contains no libelous or unlawful statements, does not infringe the privacy of others, or contains material or instructions that might cause harm or injury. The corresponding author shall indemnify and hold the Editors and its agents and licensees harmless from any damages, costs, and expenses (including reasonable attorney’s fees and costs of settlement) resulting by reason of any claim, action, or proceeding finally sustained or settled inconsistent with the foregoing warranties and representations. (11) All manuscripts are screened for plagiarism, which implies immediate rejection. Suspected plagiarism is handled in accordance with the COPE flowcharts (http://publicationethics.org/resources/flowcharts).</p> <p>Every author or co-author of any article published in this Journal is solely responsible for the contents of the article, for the statement made in their paper and for the material sent. Every author or co-author needs to fully comply with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): «<em>Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying a natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited».</em></p> <p><strong>PRINTING CONTRIBUTION.</strong> The corresponding author accept to be charged Euro 300.00 as printing contribution for the article (for articles submitted from March 1, 2021). Payment details will be sent with galley proofs.</p> <p><strong>PRIVACY POLICY STATEMENT. </strong>Personal data of the author will be managed by the Publisher in full compliance with the current legislation on the privacy protection (art.&nbsp;13 of EU regulation 2016/6799). According to articles 15-20 of the GDPR, any author may&nbsp;exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or cancel them.&nbsp;Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons.&nbsp;In the case that the author believes that processing of his/her own personal data infringes the of GDPR regulation, he/she has the right to make a complaint&nbsp;to the Supervisory Authority for the Protection of Personal Data according to art.&nbsp;77 of the GDPR. Controller of data processing, according to art.&nbsp;4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Editore Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n.&nbsp;1. To exercise the rights of GDPR referred to in paragraph 6 of the same article, you can address any request for information to the following e-mail:&nbsp;privacy@pacinieditore.it. For further information refer to the website:&nbsp;https://www.actaitalica.it/about/privacy</p> <p><strong>FINANCIAL DISCLOSURE. </strong>All authors must state any information that may be perceived as potential <em>conflict of interest</em>. All authors must disclose all their affiliations including any relevant personal or institutional financial involvement (employment by an industrial concern, consultancies, honoraria, speakers bureau, stock ownership or options, expert testimony, grants received or pending, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with a company or its products, royalties, donation of medical equipment, etc.) with any organization that to any author’s knowledge has a direct interest, particularly a financial interest, in the subject matter or materials discussed. This declaration will be treated by the Editor as confidential while the paper is under review, and will not be made known to Reviewers. &nbsp;Please indicate on the <strong>Authorship Statement Form</strong> whether or not you have or may have such a conflict of interest regarding the content of this article and is the nature of it.</p> <p><strong>COPYRIGHT TRANSFER AGREEMENT. </strong>(a) Authors assign to “Acta Otorhinolaryngologica Italica”, all copyright in and to the article, including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the article in whole or in part, in electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media of expression now known or later developed, and to license or permit others to do so. (b) The authors retain all proprietary rights, other than copyright, such as patent rights. The authors retain the right to reuse any portion of the work, without charge, in personal compilations or other publications consisting solely of the author(s’) own works, including the author(s’) personal web home page, and to make copies of all or part of the Work for the author(s’) use for lecture or classroom purposes. The corresponding author declares that any person named as co-author of the article is aware of the submission and has agreed to being so named. The corresponding author accepts responsibility for releasing this material on behalf of any and all co-authors. The corresponding author declares that statements and opinions given in the article are the expression of the authors. Responsibility for the content of the article rests upon the authors.</p> <p><strong>&nbsp;</strong></p> cesare.piazza@unibs.it (Cesare Piazza) support-actaorl@pacinieditore.it (Manuela Mori, Valentina Barberi) Tue, 23 Apr 2024 08:53:58 +0000 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 A systematic review of randomised controlled trials on topical nasal steroids https://www.actaitalica.it/article/view/2745 <p><strong>Introduction</strong>. Intranasal corticosteroids (INCs) are the first line of therapy for chronic sinonasal conditions such as rhinitis and rhinosinusitis. Among these, one of the most frequently used is beclomethasone dipropionate (BDP). Over the years many studies have evaluated the efficacy of BDP as part of therapy for chronic rhinosinusitis (CRS) and allergic rhinitis (AR) along with nasal washes, which seems to be very well tolerated. Objective. To analyse the data in the literature regarding the various therapeutic regimens of BDP in different sinonasal disease and their efficacy and tolerability. <br><strong>Materials and methods</strong>. Using different search engines, the posology, efficacy, and tolerability of BDP were reviewed and a total of 64 full-length articles were examined for eligibility. After applying inclusion and exclusion criteria, 4 articles were reviewed. <br><strong>Results</strong>. BDP is among the group of INCs with significant improvement of nasal symptoms and has good efficacy and safety. <br><strong>Conclusions</strong>. BDP nasal spray is one of the most frequently prescribed INC for rhinitis and rhinosinusitis. Treatment with BDP resulted in significant and clinically meaningful improvements in nasal symptoms associated with AR and CRS. BDP is well tolerated, and the safety profile is similar to that of placebo in most patients. These results, in conjunction with the significant benefit reported in subjects with CRS and AR, provide convincing evidence of the overall effectiveness of BDP for the treatment of the full spectrum of sinonasal disease.</p> Chiara Zeroli, Armela Gorica, Giulia Monti, Paolo Giocondo Maria Castelnuovo, Maurizio Bignami, Alberto Macchi Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2745 Mon, 22 Apr 2024 09:54:54 +0000 Microsurgery in carotid body paraganglioma https://www.actaitalica.it/article/view/2761 <p><strong>Objectives</strong>. In carotid paraganglioma surgery, magnification is crucial to properly evaluate the anatomical relationships between mass, carotid wall, cranial nerves, tumour vascular supply and fascial envelope. The aims of this study are to describe the microsurgical technique, along with the underlying microsurgical anatomy, and to assess outcomes in terms of disease control, complications and functional results. <br><strong>Methods</strong>. Twenty-six patients, accounting for 29 carotid paragangliomas, treated with microsurgery by the same senior surgeon over a 35-year period, were included. <br><strong>Results</strong>. No carotid injury requiring repair, nor peri- or post-operative stroke occurred in this series. No surgical injury of the main trunk of VII to XII cranial nerves occurred. Complete excision was obtained in all cases and no recurrence was observed during follow-up. <br><strong>Conclusions</strong>. The small study size and its retrospective nature suggests caution; however, our results show that microsurgery can allow a safe and precise dissection of the carotids and nerves.</p> Antonio Mazzoni, Leonardo Franz, Elisabetta Zanoletti Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2761 Mon, 22 Apr 2024 10:01:06 +0000 Global research on sinonasal inverted papilloma over the past two decades: a bibliometric analysis https://www.actaitalica.it/article/view/2522 <p><strong>Objective</strong>.&nbsp;This study aimed to investigate the global research status, hot topics, and prospects in the field of sinonasal inverted papilloma (SNIP) through bibliometric analysis.<br><strong>Methods</strong>. The literature on SNIP was retrieved and downloaded from the Web of Science Core Collection from 2002 to 2021. The bibliometric and visualisation networks of SNIP were constructed using VOSviewer 1.6.18, CiteSpace 6.1. R2, and a bibliometric online analysis platform.<br><strong>Results</strong>. A total of 560 original articles about SNIP research were included, involving 2,457 authors from 610 institutions in 45 countries. The number of SNIP publications showed an overall rising trend, with an average annual output of 28 articles and almost 3 times as many articles published in 2020 as in 2002. The analysis of keyword burst detection indicated that EGFR mutation, malignant transformation and infection are emerging research hotspots. Moreover, EGFR mutation, KRAS mutation, malignant tumour, metallothionein 2a gene, pre-operative diagnosis, HPV-negative tumour, and expression were among the 11 key clusters of co-cited references.<br><strong>Conclusions</strong>. This study provided a comprehensive, systematic, and objective analysis and visualised knowledge map of SNIP over the past 2 decades. In particular, current hotspots and prospective trends in the field of SNIP have been identified. These results highlight the future direction of SNIP research for rhinologists.</p> Dachuan Fan, Yongjun Zhu, Jianming Yang, Jinxiao Hou Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2522 Fri, 29 Dec 2023 00:00:00 +0000 Retrospective comparison of first-line treatments for odontogenic sinusitis based on duration of symptoms https://www.actaitalica.it/article/view/2648 <p><strong>Objectives</strong>. To investigate the clinical efficacy of dental treatment and endoscopic sinus surgery (ESS), each primary/combined treatment modality, in patients with odontogenic sinusitis (ODS), according to its phase, acute or chronic. <br><strong>Materials and methods</strong>. We retrospectively reviewed clinical data on 172 patients diagnosed with ODS. They were divided into two groups: acute (≤ 3 months; 90 patients) and chronic (&gt; 3 months; 82 patients) ODS. The success rate and time to resolution of each primary/combined treatment modality were compared between the two groups. <br><strong>Results</strong>. In both ODS groups, the success rate was highest with combined ESS and dental therapy, followed by ESS alone and dental therapy alone. ESS outperformed dental therapy (96.6% <em>vs</em> 65.5% for acute ODS, p = 0.011; 80.6% <em>vs</em> 56.5% for chronic ODS, p = 0.046) and led to quicker resolution of symptoms for acute ODS than dental therapy (0.9 <em>vs</em> 1.7 months, p = 0.012). In the comparison between ESS alone and combined therapy, no significant difference was observed for acute ODS, whereas combined therapy demonstrated a superior success rate for chronic ODS (100% <em>vs</em> 80.6%, p = 0.046). <br><strong>Conclusions</strong>. In our study, the clinical utility of dental treatment and/or ESS depended on the morbidity period of ODS. For chronic ODS, combined ESS and dental treatment seems to be an effective first-line treatment.</p> Kyung Won Kwon, Jang Wook Gwak, Yoo-Sam Chung Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2648 Thu, 29 Feb 2024 00:00:00 +0000 Nasal nitric oxide measurement in allergic rhinitis and non-allergic rhinitis: a meta-analysis https://www.actaitalica.it/article/view/2634 <p>The goal of this meta-analysis was to study nasal nitric oxide (nNO) measurements in allergic rhinitis (AR) and non-allergic rhinitis (non-AR). The protocol was registered with PROSPERO (no: CRD4202124828). Electronic databases from PubMed, Google Scholar, Scopus, Web of Science, and Cochrane were all thoroughly searched and studies were chosen based on the qualifying requirements. The quality of the studies was evaluated by Joanna Briggs Institute evaluation tools, and publication bias using funnel plots. The metaanalysis included 18 studies, whereas the systematic review included 20 studies, totaling 3097 participants (1581 AR, 458 non-AR, and 1058 healthy/control). Patients with AR had significantly greater nNO levels than the control group, although this did not change significantly before or after treatment. AR patients had significantly greater nNO levels than non-AR patients, but there was no significant difference between non-AR patients and healthy controls. Nineteen of the studies were of high quality and the remaining one was of moderate quality. nNO measurement has a promising role in the management of AR and non-AR patients, but more investigations are needed to document clinical benefits.</p> Ahmad Faiz Dahlan, Md Asiful Islam, Norasnieda Md Shukri, Baharudin Abdullah Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2634 Mon, 22 Apr 2024 10:11:47 +0000 Binaural hearing in monaural conductive or mixed hearing loss fitted with unilateral Bonebridge https://www.actaitalica.it/article/view/2752 <p style="font-weight: 400;"><strong>Objective</strong>. To determine the benefits of binaural hearing rehabilitation in patients with monaural conductive or mixed hearing loss treated with a unilateral bone conduction implant (BCI). <br><strong>Methods</strong>. This monocentric study includes 7 patients with monaural conductive or mixed hearing loss who underwent surgical implantation of a unilateral BCI (Bonebridge, Med- El). An ITA Matrix test was performed by each patient included in the study - without and with the BCI and in three different settings – to determine the summation effect, squelch effect and head shadow effect. Subjective hearing benefits were assessed using the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire. <br><strong>Results</strong>. The difference in signal to noise ratio of patients without and with BCI was 0.79 dB in the summation setting (p &lt; 0.05), 4.62 dB in the head shadow setting (p &lt; 0.05) and 1.53 dB (p = 0.063) in the squelch setting. The APHAB questionnaire revealed a subjective discomfort in the presence of unexpected sounds in patients using a unilateral BCI (aversiveness score) compared to the same environmental situations without BCI, with a mean discomfort score of 69.00% (SD ± 21.24%) with monaural BCI versus 25.67% (SD ± 16.70%) without BCI (difference: -43.33%, p &lt; 0.05). In terms of global score, patients wearing a unilateral Bonebridge implant did not show any significant differences compared to those without hearing aid (difference: -4.00%, p = 0.310).<br><strong>Conclusions</strong>. Our study shows that the use of a unilateral BCI in patients affected by monaural conductive or mixed hearing loss can improve speech perception under noise conditions due to the summation effect and to the decrease of the head shadow effect. However, since monaural BCIs might lead to discomfort under noise conditions in some subjects, a pre-operative assessment of the possible individual benefit of a monaural BCI should be carried out in patients affected by unilateral conductive or mixed hearing loss in order to investigate the possible additional effect of the fitting of hearing aids.</p> Andrea Canale, Anastasia Urbanelli, Roberto Albera, Maria Gragnano, Valerio Bordino, Giuseppe Riva, Eugenio Sportoletti Baduel, Andrea Albera Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2752 Mon, 22 Apr 2024 10:18:47 +0000 Effect of stapes demineralisation on the development of cochlear otosclerosis https://www.actaitalica.it/article/view/2389 <p><strong>Objective</strong>. The involvement of the inner ear in otosclerosis may lead to the development of cochlear otosclerosis. The aim of this study was to analyse changes in the chemical composition and microstructure of the stapes in the course of otosclerosis compared to healthy stapes. <br><strong>Materials and methods</strong>. This analysis included 31 patients with otosclerosis and 9 patients without otosclerosis. Microanalytical and diffraction techniques were used to assess the elemental distribution and orientation topography of the stapes. <br><strong>Results</strong>. The concentration of Ca2+ in the study group was significantly lower in the area of the anterior crus of the stapes than in the posterior crus. A reduction in the Ca2+/P3+ ratio in the anterior crus was associated with deteriorated bone conduction and tinnitus. Degradation of the stapes microstructure in the area of otosclerotic lesions was observed with scanning electron microscopy. <br><strong>Conclusions</strong>. Bone remodelling is most significant at the closest location to typical otosclerotic lesions with hydroxyapatite porosity and scale-like bone formation according to scanning electron microscopy. There is a relationship between the disturbance of calcium metabolism and the development of clinical symptoms of cochlear otosclerosis.</p> Maciej Wiatr, Robert Bartoszewicz, Kazimierz Niemczyk, Agnieszka Wiatr Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2389 Thu, 29 Feb 2024 00:00:00 +0000 Surgical management of advanced sinonasal cancer: a 10-year mono-institutional experience https://www.actaitalica.it/article/view/2375 <p><strong>Objective</strong>. Endoscopic endonasal surgery is effective in the treatment of sinonasal cancers. However, in cases of well-differentiated locally advanced neoplasms as well as recurrences, the most appropriate treatment is debated. The purpose of this study is to report a monoinstitutional experience on craniofacial surgery performed in a tertiary-care referral centre. <br><strong>Methods</strong>. This was a retrospective analysis of 90 patients treated with transcranial and/ or transfacial resection for sinonasal cancer between 2010 and 2020. Outcome measures included overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS) and recurrence-free survival (RFS). <br><strong>Results</strong>. The 5-year OS, DSS and DFS were 48.2%, 60.6% and 28.7%, respectively. Factors correlated with prognosis were pT-classification (p = 0.002), histotype (p = 0.012) and dural involvement (p = 0.004). Independent prognostic factors were orbital apex infiltration (p = 0.03), age (p = 0.002) and adjuvant therapy (p = 0.03). <br><strong>Conclusions</strong>. When endoscopic endonasal surgery is contraindicated and chemoradiotherapy is not appropriate, craniofacial and transfacial approaches still represent an option to consider, despite the non-negligible morbidity.</p> Giorgio Sileo, Alberto Daniele Arosio, Alessia Lambertoni, Paolo Battaglia, Maurizio Bignami, Luigi Valdatta, Paolo Castelnuovo, Mario Turri-Zanoni Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2375 Mon, 22 Apr 2024 10:31:50 +0000 Comment to the article “Mandibular reconstruction using a new design for a patient-specific plate to support a fibular free flap and avoid the double-barrel technique” by Tarsitano et al., 2021 https://www.actaitalica.it/article/view/2638 James Pallot, Alex Goodson , Peter Evans, Madhav Kittur Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2638 Thu, 29 Feb 2024 00:00:00 +0000 Opportunities and obstacles of electronic health records in Italy: towards enhanced surgical care https://www.actaitalica.it/article/view/2727 Michaele Francesco Corbisiero, Davide Rizzo, Roberto Gallus, Pierpaolo Loreti, Lorenzo Bracciale, Francesco Bussu Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.actaitalica.it/article/view/2727 Mon, 22 Apr 2024 10:40:17 +0000